Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients
Description
CONCLUSIONS: In patients hospitalized for COVID-19, antibodies against AT1R and ETAR are increased compared to controls and patients with ARDS due to other causes than COVID-19. The baseline antibody titers do not correlate with inflammatory markers
